Mesoblast (MSB) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Mesoblast ADRs Rise 22%, FDA Approves Ryoncil for Pediatric Patients -- UpdateDecember 19 at 10:05 AM | marketwatch.comMesoblast Finally Gets Its Approval In GVHD: Where Now?December 19 at 10:05 AM | seekingalpha.comMesoblast shares rocket on FDA approval, but CEO says risks remainDecember 19 at 5:05 AM | afr.comFDA Approves Mesoblast's Cell Therapy To Treat Steroid-refractory Acute Graft-versus-host DiseaseDecember 19 at 12:05 AM | markets.businessinsider.com3 ASX 300 shares smashing new highs while the market divesDecember 19 at 12:05 AM | fool.com.auMesoblast ADRs Rise 22%, Company Joining Nasdaq Biotechnology IndexDecember 18, 2024 | marketwatch.comMesoblast share price rockets 30% on big US FDA newsDecember 18, 2024 | msn.comJPMorgan Chase Ceases Substantial Holding in MesoblastDecember 17, 2024 | markets.businessinsider.comFDA Grants RMAT Designation To Mesoblast's Revascor For Pediatric Hypoplastic Left Heart SyndromeDecember 5, 2024 | markets.businessinsider.comWhat on Earth is happening with Mesoblast shares today?December 5, 2024 | fool.com.auChartWatch ASX Scans: Aristocrat Leisure, Bravura Solutions, Mesoblast, MTM Critical Metals, Pro Medicus, Qantas, Syntara, WorleyDecember 3, 2024 | msn.comMesoblast Limited's (ASX:MSB) 17% gain last week benefited both retail investors who own 54% as well as insidersNovember 29, 2024 | finance.yahoo.comJPMorgan Chase Takes Significant Stake in MesoblastNovember 21, 2024 | markets.businessinsider.com3 ASX healthcare shares going gangbusters on ThursdayNovember 15, 2024 | msn.comUp 427% this year, why today is a big day for Mesoblast sharesNovember 14, 2024 | msn.comAustralia shares higher at close of trade; S&P/ASX 200 up 0.37%November 14, 2024 | msn.comMesoblast Limited Issues Unquoted Warrants in Strategic MoveNovember 12, 2024 | msn.comAustralia shares lower at close of trade; S&P/ASX 200 down 0.12%October 24, 2024 | msn.com3 High Growth Tech Stocks in Australia to WatchOctober 8, 2024 | uk.finance.yahoo.comAustralia shares lower at close of trade; S&P/ASX 200 down 0.67%October 4, 2024 | msn.com2 ASX healthcare shares rocketing over 16% on Big US newsOctober 3, 2024 | fool.com.auCashed up & ready to go: Mesoblast forges funding deal with top shareholderSeptember 30, 2024 | msn.comIf you'd invested $6,000 in the ASX 300 stock in January, you'd have $22,551 today!September 27, 2024 | msn.comEvening Wrap: ASX 200 notches an important record as broad-based gain sees us bid farewell to another earnings seasonAugust 30, 2024 | msn.comMesoblast Full Year 2024 Earnings: Misses ExpectationsAugust 30, 2024 | finance.yahoo.comBell Potter Sticks to Their Buy Rating for Mesoblast Limited (MEOBF)August 30, 2024 | markets.businessinsider.comBrazil finance chief says he suggested new cenbank head be picked by SeptemberAugust 28, 2024 | ca.finance.yahoo.comInvestors in Mesoblast (ASX:MSB) have seen impressive returns of 154% over the past yearAugust 21, 2024 | finance.yahoo.comLWB1.BE,0P0001JS8Q,0 (LWB1.BE)July 25, 2024 | sg.finance.yahoo.comLWB1.SG,0P0001JSPL,0 (LWB1.SG)July 21, 2024 | finance.yahoo.comIt’s horses for courses and April was ASX Resources: Selfwealth’s latest best ofMay 22, 2024 | msn.comInsider still buying Mesoblast shares despite 230% rise this year: Should you buy?May 13, 2024 | msn.com9 ASX All Ords shares elevated to 'strong buy' status in AprilMay 2, 2024 | msn.comIf you invested $6,000 in Mesoblast shares a month ago you'd have $15,636 now!April 23, 2024 | fool.com.auWhy the Mesoblast share price can rise another 60%April 5, 2024 | msn.comTop 5 Health Care Stocks That May Plunge In MarchMarch 28, 2024 | msn.comAfter Almost 4 Years, FDA Says Mesoblast Phase 3 Therapy Data Can Support Resubmission For Serious Complications in Children Following Stem Cell TransplantMarch 27, 2024 | finance.yahoo.comMesoblast gains as FDA backs regulatory plans for cell therapyMarch 26, 2024 | msn.comMESO Mar 2024 3.000 putMarch 15, 2024 | finance.yahoo.comWhy is the Mesoblast share price jumping 16% on Monday?March 11, 2024 | msn.comMesoblast : FDA Backs Accelerated Approval For Rexlemestrocel-L In Heart Failure PatientsMarch 11, 2024 | markets.businessinsider.comAustralia stocks higher at close of trade; S&P/ASX 200 up 0.39%March 7, 2024 | msn.comMESO Mar 2024 2.000 putFebruary 17, 2024 | finance.yahoo.comWhat investors can learn from analysing R&D spendingFebruary 4, 2024 | afr.comMesoblast surges on FDA ‘rare paediatric disease’ designationJanuary 19, 2024 | afr.comIn Case You Missed It: A thing, a different thing and an amusing play on words, I guessJanuary 19, 2024 | msn.comMesoblast (ASX:MSB) investors are sitting on a loss of 88% if they invested three years agoJanuary 8, 2024 | finance.yahoo.comWhy is the Mesoblast share price sinking 25% on Tuesday?December 4, 2023 | fool.com.auWhy are Mesoblast shares charging 5% higher today?November 27, 2023 | fool.com.auMesoblast Partners With Blood and Marrow Transplant Clinical Trials Network (BMT CTN) on Pivotal Trial in Adults With SR-aGVHDNovember 21, 2023 | finance.yahoo.com Get Mesoblast News Delivered to You Automatically Sign up to receive the latest news and ratings for MSB and its competitors with MarketBeat's FREE daily newsletter. Email Address This is the worst sign for the U.S. stock market in 50 years (Ad)The Dow recently posted its worst losing streak since 1974. And one of America's most accurate analysts now says this is just the beginning of a new crisis that could be worse than the COVID crash, the dot-com crash, and even the Great Depression. Introducing "The Dead Zone" Click here to see Dan's new, urgent warning about the U.S. market for 2025. MSB Media Mentions By Week MSB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MSB News Sentiment▼0.570.60▲Average Medical News Sentiment MSB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MSB Articles This Week▼80▲MSB Articles Average Week Get Mesoblast News Delivered to You Automatically Sign up to receive the latest news and ratings for MSB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ABQQ News Today AC News Today AGFMF News Today AGNCP News Today AGNCO News Today AGNCN News Today AGNCM News Today AGNCL News Today KKR News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (ASX:MSB) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is ...Brownstone Research | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mesoblast Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Mesoblast With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.